Zhejiang Gongdong Medical Technology Co Ltd (605369) - Net Assets
Based on the latest financial reports, Zhejiang Gongdong Medical Technology Co Ltd (605369) has net assets worth CN¥1.73 Billion CNY (≈ $253.73 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.13 Billion ≈ $311.26 Million USD) and total liabilities (CN¥393.21 Million ≈ $57.54 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 605369 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.73 Billion |
| % of Total Assets | 81.51% |
| Annual Growth Rate | 31.85% |
| 5-Year Change | 42.19% |
| 10-Year Change | N/A |
| Growth Volatility | 60.6 |
Zhejiang Gongdong Medical Technology Co Ltd - Net Assets Trend (2016–2024)
This chart illustrates how Zhejiang Gongdong Medical Technology Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 605369 total asset value for the complete picture of this company's asset base.
Annual Net Assets for Zhejiang Gongdong Medical Technology Co Ltd (2016–2024)
The table below shows the annual net assets of Zhejiang Gongdong Medical Technology Co Ltd from 2016 to 2024. For live valuation and market cap data, see market value of Zhejiang Gongdong Medical Technology Co .
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.72 Billion ≈ $251.33 Million |
+4.82% |
| 2023-12-31 | CN¥1.64 Billion ≈ $239.77 Million |
+2.91% |
| 2022-12-31 | CN¥1.59 Billion ≈ $232.99 Million |
+14.71% |
| 2021-12-31 | CN¥1.39 Billion ≈ $203.11 Million |
+14.91% |
| 2020-12-31 | CN¥1.21 Billion ≈ $176.76 Million |
+198.07% |
| 2019-12-31 | CN¥405.25 Million ≈ $59.30 Million |
+18.69% |
| 2018-12-31 | CN¥341.42 Million ≈ $49.96 Million |
+35.21% |
| 2017-12-31 | CN¥252.52 Million ≈ $36.95 Million |
+34.27% |
| 2016-12-31 | CN¥188.07 Million ≈ $27.52 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Zhejiang Gongdong Medical Technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 823.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥781.01 Million | 45.75% |
| Common Stock | CN¥157.58 Million | 9.23% |
| Other Components | CN¥768.59 Million | 45.02% |
| Total Equity | CN¥1.71 Billion | 100.00% |
Zhejiang Gongdong Medical Technology Co Ltd Competitors by Market Cap
The table below lists competitors of Zhejiang Gongdong Medical Technology Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BlackRock Utility & Infrastructure Trust
NYSE:BUI
|
$635.64 Million |
|
E&R Engineering
TWO:8027
|
$635.83 Million |
|
Shenzhen Water Planning & Design Institute Co. Ltd.
SHE:301038
|
$635.90 Million |
|
AbClon Inc
KQ:174900
|
$635.95 Million |
|
Hunan Huasheng Co Ltd
SHG:600156
|
$635.49 Million |
|
Mako Mining Corp
V:MKO
|
$635.07 Million |
|
Guangdong Weide Information Technology Co. Ltd. A
SHG:688171
|
$634.88 Million |
|
Guangzhou Grandbuy Co Ltd
SHE:002187
|
$634.86 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Zhejiang Gongdong Medical Technology Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,638,538,971 to 1,707,180,400, a change of 68,641,429 (4.2%).
- Net income of 171,632,798 contributed positively to equity growth.
- Dividend payments of 81,226,163 reduced retained earnings.
- Share repurchases of 38,878,850 reduced equity.
- Other factors increased equity by 17,113,644.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥171.63 Million | +10.05% |
| Dividends Paid | CN¥81.23 Million | -4.76% |
| Share Repurchases | CN¥38.88 Million | -2.28% |
| Other Changes | CN¥17.11 Million | +1.0% |
| Total Change | CN¥- | 4.19% |
Book Value vs Market Value Analysis
This analysis compares Zhejiang Gongdong Medical Technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.82x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 8.77x to 1.82x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | CN¥2.25 | CN¥19.70 | x |
| 2017-12-31 | CN¥3.02 | CN¥19.70 | x |
| 2018-12-31 | CN¥4.08 | CN¥19.70 | x |
| 2019-12-31 | CN¥4.89 | CN¥19.70 | x |
| 2020-12-31 | CN¥10.79 | CN¥19.70 | x |
| 2021-12-31 | CN¥12.39 | CN¥19.70 | x |
| 2022-12-31 | CN¥14.21 | CN¥19.70 | x |
| 2023-12-31 | CN¥14.40 | CN¥19.70 | x |
| 2024-12-31 | CN¥10.84 | CN¥19.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Zhejiang Gongdong Medical Technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.05%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 15.39%
- • Asset Turnover: 0.57x
- • Equity Multiplier: 1.14x
- Recent ROE (10.05%) is below the historical average (20.10%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 32.18% | 16.30% | 1.05x | 1.87x | CN¥41.71 Million |
| 2017 | 17.52% | 10.26% | 1.31x | 1.30x | CN¥19.00 Million |
| 2018 | 24.87% | 17.60% | 1.04x | 1.36x | CN¥50.78 Million |
| 2019 | 28.03% | 20.54% | 1.03x | 1.32x | CN¥73.06 Million |
| 2020 | 18.70% | 27.23% | 0.60x | 1.14x | CN¥105.09 Million |
| 2021 | 22.40% | 26.04% | 0.71x | 1.22x | CN¥172.18 Million |
| 2022 | 20.48% | 22.20% | 0.79x | 1.17x | CN¥166.82 Million |
| 2023 | 6.66% | 11.19% | 0.52x | 1.15x | CN¥-54.73 Million |
| 2024 | 10.05% | 15.39% | 0.57x | 1.14x | CN¥914.76K |
Industry Comparison
This section compares Zhejiang Gongdong Medical Technology Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,873,914,557
- Average return on equity (ROE) among peers: 5.05%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Zhejiang Gongdong Medical Technology Co Ltd (605369) | CN¥1.73 Billion | 32.18% | 0.23x | $635.62 Million |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $1.89 Billion | 4.92% | 0.86x | $523.48 Million |
| Blue Sail Medical Co Ltd (002382) | $9.82 Billion | 17.91% | 0.74x | $1.10 Billion |
| Andon Health Co Ltd (002432) | $1.60 Billion | 4.16% | 0.21x | $5.00 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $742.08 Million | 26.74% | 1.36x | $1.28 Billion |
| Guangzhou Improve Med Instrument (300030) | $563.53 Million | 4.77% | 0.17x | $376.43 Million |
| QITIAN Technology Group Co Ltd (300061) | $2.47 Billion | -32.17% | 0.22x | $924.78 Million |
| Shanghai Tofflon Science Tech (300171) | $8.05 Billion | 2.41% | 0.62x | $1.47 Billion |
| Truking Technology Ltd (300358) | $2.32 Billion | 6.92% | 0.71x | $1.02 Billion |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $718.02 Million | 8.59% | 0.60x | $770.09 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $574.90 Million | 6.24% | 0.48x | $2.50 Billion |
About Zhejiang Gongdong Medical Technology Co Ltd
Zhejiang Gongdong Medical Technology Co., Ltd. researches, develops, produces, and sells disposable medical consumables in China. Its products include blood collection tubes, needles and needle holders, and sharp containers; cell culture dishes, plates, bottles, flasks, and serological pipette solutions; laboratory consumables, such as petri dishes, centrifuge and cryo tubes, pipette tips, transf… Read more